SHSE:600789 (China)
Â
Class A
Â¥
8.81
(+2.68%)
Nov 29
Business Description
Shandong Lukang Pharmaceutical Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE000000P61
Share Class Description:
SHSE:600789: Class ACompare
Compare
Traded in other countries / regions
600789.China IPO Date
1997-02-26Description
Shandong Lukang Pharmaceutical Co Ltd is a bio-pharmaceuticals company. It is engaged in manufacturing antibiotics, semi-synthetic antibiotics for human use, bio-pharmaceuticals for veterinary and agriculture use, intermediates, resins, starches, glucose and amino acids.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.33 | |||||
| Equity-to-Asset | 0.43 | |||||
| Debt-to-Equity | 0.72 | |||||
| Debt-to-EBITDA | 5.55 | |||||
| Interest Coverage | 5 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 2.04 | |||||
| Beneish M-Score | -2.23 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 14.9 | |||||
| 3-Year EBITDA Growth Rate | 10.1 | |||||
| 3-Year EPS without NRI Growth Rate | 171.4 | |||||
| 3-Year Book Growth Rate | 3.4 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58.04 | |||||
| 9-Day RSI | 52.4 | |||||
| 14-Day RSI | 52.82 | |||||
| 6-1 Month Momentum % | 3.71 | |||||
| 12-1 Month Momentum % | 7.02 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | |||||
| Quick Ratio | 0.83 | |||||
| Cash Ratio | 0.26 | |||||
| Days Inventory | 103.8 | |||||
| Days Sales Outstanding | 54.37 | |||||
| Days Payable | 118.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.02 | |||||
| Dividend Payout Ratio | 0.26 | |||||
| 3-Year Dividend Growth Rate | 6.9 | |||||
| Forward Dividend Yield % | 1.02 | |||||
| 5-Year Yield-on-Cost % | 2.4 | |||||
| 3-Year Average Share Buyback Ratio | -0.6 | |||||
| Shareholder Yield % | -0.56 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 23.62 | |||||
| Operating Margin % | 6.68 | |||||
| Net Margin % | 6.59 | |||||
| FCF Margin % | 4.79 | |||||
| ROE % | 10.79 | |||||
| ROA % | 4.52 | |||||
| ROIC % | 6 | |||||
| ROC (Joel Greenblatt) % | 11.98 | |||||
| ROCE % | 9.17 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 19.58 | |||||
| PE Ratio without NRI | 25.54 | |||||
| Shiller PE Ratio | 48.11 | |||||
| Price-to-Owner-Earnings | 266.97 | |||||
| PEG Ratio | 2.18 | |||||
| PS Ratio | 1.28 | |||||
| PB Ratio | 2.03 | |||||
| Price-to-Tangible-Book | 2.61 | |||||
| Price-to-Free-Cash-Flow | 25.69 | |||||
| Price-to-Operating-Cash-Flow | 13.87 | |||||
| EV-to-EBIT | 19.44 | |||||
| EV-to-EBITDA | 19.44 | |||||
| EV-to-Revenue | 1.61 | |||||
| EV-to-FCF | 33.67 | |||||
| Price-to-Projected-FCF | 8.31 | |||||
| Price-to-DCF (Earnings Based) | 1.14 | |||||
| Price-to-DCF (FCF Based) | 2.22 | |||||
| Price-to-Median-PS-Value | 0.71 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.82 | |||||
| Price-to-Graham-Number | 1.72 | |||||
| Earnings Yield (Greenblatt) % | 5.14 | |||||
| FCF Yield % | 3.68 | |||||
| Forward Rate of Return (Yacktman) % | 12.66 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shandong Lukang Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 6,081.816 | ||
| EPS (TTM) (Â¥) | 0.45 | ||
| Beta | 0.8 | ||
| Volatility % | 37.14 | ||
| 14-Day RSI | 52.82 | ||
| 14-Day ATR (Â¥) | 0.383209 | ||
| 20-Day SMA (Â¥) | 8.941 | ||
| 12-1 Month Momentum % | 7.02 | ||
| 52-Week Range (Â¥) | 5.04 - 10.67 | ||
| Shares Outstanding (Mil) | 898.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shandong Lukang Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shandong Lukang Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shandong Lukang Pharmaceutical Co Ltd Frequently Asked Questions
What is Shandong Lukang Pharmaceutical Co Ltd(SHSE:600789)'s stock price today?
The current price of SHSE:600789 is ¥8.81. The 52 week high of SHSE:600789 is ¥10.67 and 52 week low is ¥5.04.
When is next earnings date of Shandong Lukang Pharmaceutical Co Ltd(SHSE:600789)?
The next earnings date of Shandong Lukang Pharmaceutical Co Ltd(SHSE:600789) is .
Does Shandong Lukang Pharmaceutical Co Ltd(SHSE:600789) pay dividends? If so, how much?
The Dividend Yield %  of Shandong Lukang Pharmaceutical Co Ltd(SHSE:600789) is 1.02% (As of Today), Highest Dividend Payout Ratio of Shandong Lukang Pharmaceutical Co Ltd(SHSE:600789) was 4.5. The lowest was 0.15. And the median was 0.44. The  Forward Dividend Yield % of Shandong Lukang Pharmaceutical Co Ltd(SHSE:600789) is 1.02%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers